INCREASING FACTOR VIII LEVELS TO ACHIEVE ZERO BLEEDING IN PATIENTS WITH SEVERE HAEMOPHILIA: A SINGLE CENTRE EXPERIENCE

被引：0
|
作者：
Clavero-Lopez, R. [1 ]
Lopez-Jaime, F. J. [1 ]
Mena-Santano, A. M. [1 ]
Calavia-Aranda, E. M. [1 ]
Fernandez-Bello, I. [1 ]
Montano, A. [1 ,2 ]
机构：
[1] IBIMA, Reg Univ Hosp Malaga, Hemostasis & Thrombosis Unit, Malaga, Spain
[2] Univ Salamanca, Salamanca, Spain
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO094
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [41] X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers
    Garagiola, Isabella
    Mortarino, Mimosa
    Siboni, Simona Maria
    Boscarino, Marco
    Mancuso, Maria Elisa
    Biganzoli, Marina
    Santagostino, Elena
    Peyvandi, Flora
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2021, 29 (02) : 241 - 249
  • [42] The detection and management of inhibitors in severe haemophilia patients - the experience of a large UK paediatric tertiary haemophilia centre
    Horgan, C.
    Elmoamly, S.
    Patel, J.
    Rebbapragada, H.
    Motwani, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 135 - 136
  • [43] Recombinant Fusion Factor VIII-Fc Fusion Protein in Severe Haemophilia A Patients
    Le Quellec, Sandra
    HEMATOLOGIE, 2014, 20 (06): : 304 - 306
  • [44] Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product
    Yee, TT
    Williams, MD
    Hill, FGH
    Lee, CA
    Pasi, KJ
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (03) : 1027 - 1029
  • [45] Immune system polymorphisms and factor VIII inhibitor formation in Brazilian haemophilia A severe patients
    Agostini, D.
    Rosset, C.
    Botton, M. R.
    Kappel, D. B.
    Vieira, I. A.
    Gorziza, R. P.
    Salzano, F. M.
    Bandinelli, E.
    HAEMOPHILIA, 2012, 18 (06) : e416 - e418
  • [46] Evaluation of nonneutralizing antibodies against factor VIII in severe haemophilia A patients from India
    David, Sachin
    Mathews, Nitty S.
    Singh, G. Surender
    Korula, Anu
    Aboobacker, Fouzia Nambiatheyil
    Abraham, Aby
    George, Biju
    Srivastava, Alok
    Mathews, Vikram
    Nair, Sukesh C.
    BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (07) : 337 - 340
  • [47] Baseline factor viii plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease
    Siboni, S. M.
    Biguzzi, E.
    Caiani, V
    Mistretta, C.
    Bucciarelli, P.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 500 - 501
  • [48] Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease
    Siboni, S. M.
    Biguzzi, E.
    Caiani, V.
    Mistretta, C.
    Bucciarelli, P.
    Peyvandi, F.
    HAEMOPHILIA, 2016, 22 (04) : 564 - 569
  • [49] Control of variceal bleeding in a patient with severe haemophilia A and factor VIII inhibitors using a transjugular intrahepatic portosystemic shunt
    Hurst, E.
    Talks, K.
    Hanley, J.
    HAEMOPHILIA, 2010, 16 (04) : 708 - 709
  • [50] Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis
    Chowdary, Pratima
    Fischer, Kathelijn
    Collins, Peter W.
    Cotterill, Amy
    Konkle, Barbara A.
    Blanchette, Victor
    Pipe, Steven W.
    Berntorp, Erik
    Wolfsegger, Martin
    Engl, Werner
    Spotts, Gerald
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (05) : 728 - 736
12345